IndraLab
Statements
reach
"Conversely, inhibition of USP8 by genetic ablation or its pharmacological inhibitor (DUB-IN-2) down-regulates GPX4, sensitizing tumor cells to ferroptosis, retarding tumor growth, and increasing tumor-infiltrating CD8 T cells that potentiates the PD-1/PD-L1 blockade therapy (SI Appendix, Fig. S6 E, Right)."